New organization to enable future profitable growth
As of January 1, 2022, NNIT will reorganize into three business units: Life Sciences Solutions, Cloud & Digital Solutions and Hybrid Cloud Solutions. The new organization will further strengthen NNIT’s focus on aligning customers and segments closer with preferred solutions and positioning the company for future profitable growth.
Financial results for Q3 2021 just released: Group revenue increase of 6.1% countered by lower profit margin
In Q3, we saw continued strong growth within the Life Sciences International business, and we strengthened this business further with the addition of SL Controls. Once again, our Winning Solutions strategy gained traction, as it now constitutes 54% of NNIT’s revenue compared to 46% in the same period last year.
Financial results for Q2 2021 just released: Group revenue up 1.3%
In Q2, we saw continued strong growth within the Life Sciences International business, and we strengthened this business further with the addition of SL Controls. Once again, our Winning Solutions strategy gained traction, as it now constitutes 52% of NNIT’s revenue compared to 44% in the same period last year.
NNIT further strengthens its Production IT solutions with the acquisition of Irish-based SL Controls
NNIT and SL Controls have agreed to join forces. SL Controls will further strengthen NNIT’s solutions within Production IT and is yet another step towards consolidating the NNIT Group as one of the foremost suppliers of IT services to the global life sciences industry.
New CEO to drive NNIT’s continued strategic journey
Today, NNIT’s Board of Directors have entered into an agreement with Pär Fors who will join NNIT as CEO as of June 14, 2021. Pär Fors will replace Per Kogut who has served as NNIT’s CEO since 2007.
Financial results for Q1 2021 just released: Group revenue up 1.2%
In Q1, we experienced continued strong growth within the International Life Sciences business, with Excellis performing to plan. Our Private & Public business started to see positive momentum in relation to the Winning Solutions strategy, which now constitutes 49% of NNIT’s revenue.
Interim financial report for Q4 2020/Annual Report just released
NNIT concluded 2020 in line with the financial guidance. Q4 contributed an organic double digit, profitable growth within the Life Sciences International business. The acquisition of Excellis positively added further growth.
Acquisition-boosted Orifarm selects NNIT as new strategic IT partner
Orifarm and NNIT have signed a contract for the delivery of end-to-end IT services in connection with Orifarm’s acquisition of a significant portfolio of select over-the-counter (OTC) and prescription pharmaceutical products from Japanese pharmaceutical giant Takeda.
NNIT Group acquires Excellis Health Solutions and continues its Life Sciences growth journey
NNIT acquires US-based Excellis, a leading specialized global provider in end-to-end supply chain consulting services to the life sciences industry.